Institution Directory

Clinical trials at Stanford Medicine

Sites in Stanford & Palo Alto, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1368

Shown on this page

Current sort

Live official records

Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Undifferentiated Leukemia, Myelodysplastic Syndrome, Acute Leukemia, Therapy-Related Myelodysplastic Syndrome
Interventions: Orca-T, Standard-of-Care; Biological
Lead sponsor: Orca Biosystems, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 19
States / cities: Duarte, California • Los Angeles, California • Sacramento, California + 14 more

Conditions: Inflammatory Bowel Disease, Diet Modification, Ulcerative Colitis
Interventions: Fasting Mimicking Diet, Regular Diet; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Eczema, Infantile, Eczema, Atopic Dermatitis Eczema, Atopic Dermatitis
Interventions: Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care; Combination Product · Other
Lead sponsor: Kari Nadeau, MD, PhD; Other
Eligibility: 1 Week to 12 Weeks
Enrollment: 398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 4
States / cities: Palo Alto, California • Denver, Colorado • Chicago, Illinois + 1 more

Conditions: Anterior Cruciate Ligament Reconstruction
Interventions: Tranexamic Acid, Placebos; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Schizophrenia Disorders, Mental Disorder, Psychotic Disorder
Interventions: Intracranial electrodes, TMS, TMS sham; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Crohn's Ileocolitis, Crohn Disease
Interventions: Rosuvastatin, Placebo; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Inflammatory Bowel Diseases, Diet Modification, Ulcerative Colitis
Interventions: Fermented Food-supplemented Diet, Regular Diet; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Epilepsies, Partial
Interventions: transcranial direct current stimulation (tDCS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Stanford, California

Conditions: Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases
Interventions: Rosuvastatin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Amyloid, AL Amyloidosis, Refractory AL Amyloidosis
Interventions: Daratumumab SC, Pomalidomide, Dexamethasone; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 4
States / cities: Palo Alto, California • Boston, Massachusetts • New York, New York + 1 more

Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
Interventions: Edwards EVOQUE System, Optimal Medical Therapy; Device · Drug
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 864 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 55
States / cities: Phoenix, Arizona • Tucson, Arizona • La Jolla, California + 41 more

Conditions: Diabetic Nephropathies, Diabetic Glomerulosclerosis
Interventions: There is no intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 100 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 17
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 13 more

About this Stanford Medicine institution page

What this page lists: ClinicalTrials.gov records that list Stanford Medicine in Stanford & Palo Alto, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Stanford Medicine

Filter and sort this campus

Live official records

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

Seal, Stopping Eczema and Allergy Study

The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

Brain Stimulation to the Hippocampus in Schizophrenia

Effect of Statins on Crohn's Disease

Fermented Food-Supplemented Diet in Ulcerative Colitis

Transcranial Direct Current to Treat Epilepsy at Home

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

TRISCEND II Pivotal Trial

Transformative Research in Diabetic Nephropathy

About this Stanford Medicine institution page